- Ashland announces Life Sciences business leader
- Ashland Board appoints Ashish K. Kulkarni as new director
- Ashland board authorizes quarterly dividend
- Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
- Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024
- Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast
- Ashland Board appoints Scott A. Tozier as new director
- Ashland announces executive organization changes to personal care and specialty additives
- Ashland drives gender parity, shines spotlight on the inspirational power of women from lab bench to real life, and announces Responsible Solvers™ speaker series
- Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024
More ▼
Key statistics
As of last trade Ashland Inc (ASH:NYQ) traded at 98.95, -2.02% below its 52-week high of 100.99, set on May 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 97.85 |
---|---|
High | 99.06 |
Low | 97.25 |
Bid | 98.77 |
Offer | 98.96 |
Previous close | 97.95 |
Average volume | 351.85k |
---|---|
Shares outstanding | 50.13m |
Free float | 49.84m |
P/E (TTM) | 28.43 |
Market cap | 5.02bn USD |
EPS (TTM) | 3.52 USD |
Annual div (ADY) | 1.62 USD |
---|---|
Annual div yield (ADY) | 1.65% |
Div ex-date | May 31 2024 |
Div pay-date | Jun 15 2024 |
Data delayed at least 15 minutes, as of Jun 05 2024 19:01 BST.
More ▼